心臟定位市场规模、份额及成长分析（按类型、适应症、最终用户和地区）－2025 年至 2032 年产业预测

2023 年全球心臟定位市场规模为 19.8 亿美元，预计将从 2024 年的 21.6 亿美元成长到 2032 年的 42.6 亿美元，预测期内（2025-2032 年）的复合年增长率为 8.9%。

根据市场洞察，目前约有 1,400 万美国患有心律不整，这是一个重大的健康挑战。为了解决这个普遍存在的问题，心臟定位系统应运而生，成为先进的非侵入式解决方案。这项最尖端科技可以捕捉胸部的电脉衝，并将这些讯号与电脑断层扫描资料结合，以创建心臟的详细地图。这些高解析度地图对于专家来说至关重要，使他们能够彻底分析心臟复杂的节律模式。心臟定位可以帮助医疗保健专业人员提高对心律不整的认识，从而做出更准确的诊断和个人化的治疗方案，最终改善心血管健康这一重要领域的患者预后。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管格局

心臟定位市场规模（按类型和复合年增长率）（2025-2032）

• 市场概览
• 接触式心臟定位系统
• 非接触式心臟定位系统

心臟定位市场规模（按适应症和复合年增长率）（2025-2032）

• 市场概览
• 心房颤动
• 心房扑动
• 房室结迴旋性心搏过速（AVNRT）
• 其他适应症

心臟定位市场规模（按最终用户和复合年增长率）(2025-2032)

• 市场概览
• 医院和诊所
• 诊断中心
• 其他最终用户

心臟定位市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Biosense Webster, Inc.（USA）
• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Medtronic plc（Ireland）
• Acutus Medical, Inc.（USA）
• AngioDynamics（USA）
• Koninklijke Philips NV（Netherlands）
• Biosig Technologies, Inc.（USA）
• MicroPort Scientific Corporation（China）
• Lepu Medical Technology（Beijing）Co., Ltd.（China）
• Siemens Healthineers AG（Germany）
• GE Healthcare（USA）
• Johnson & Johnson（USA）
• St. Jude Medical, Inc.（USA）
• CardioInsight Technologies, Inc.（USA）
• EP Solutions SA（Switzerland）
• CathVision ApS（Denmark）
• Acutus Medical, Inc.（USA）
• MedLumics（Spain）

结论和建议

Global Cardiac Mapping Market size was valued at USD 1.98 billion in 2023 and is poised to grow from USD 2.16 billion in 2024 to USD 4.26 billion by 2032, growing at a CAGR of 8.9% during the forecast period (2025-2032).

Market insights indicate that around 14 million Americans are currently affected by heart rhythm disorders, highlighting a significant health challenge. In response to this widespread issue, cardiac mapping systems have emerged as an advanced, non-invasive solution. This cutting-edge technology captures electrical impulses from the chest and integrates these signals with computed tomography (CT) scan data to create detailed cardiac maps. These high-resolution maps are essential for specialists, allowing them to analyze the heart's complex rhythm patterns thoroughly. By utilizing cardiac mapping, healthcare professionals can enhance their understanding of heart rhythm disorders, leading to more precise diagnoses and personalized treatment options, ultimately improving patient outcomes in this critical area of cardiovascular health.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Mapping market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Mapping Market Segments Analysis

Global Cardiac Mapping Market is segmented by Type, Indication, End User and region. Based on Type, the market is segmented into Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems. Based on Indication, the market is segmented into Atrial Fibrillation, Atrial Flutter, Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications. Based on End User, the market is segmented into Hospitals and Clinics, Diagnostic Centers and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Mapping Market

The Global Cardiac Mapping market is projected to experience significant revenue growth, driven by two primary factors: the increasing incidence of cardiovascular disorders and ongoing innovations in cardiac mapping technology. The World Health Organization (WHO) identifies cardiovascular diseases (CVDs) as the foremost cause of death worldwide, claiming around 17.9 million lives each year. Alarmingly, over 80% of deaths linked to CVDs result from heart attacks and strokes, with many victims under the age of 70. This growing health crisis, coupled with advancements in diagnostic tools, is expected to propel the demand for sophisticated cardiac mapping systems.

Restraints in the Global Cardiac Mapping Market

The Global Cardiac Mapping market faces a significant constraint due to the rising trend towards intricate treatment protocols in cardiac imaging. As medical practices evolve and the complexity of cardiac conditions increases, healthcare providers are compelled to adapt their methodologies to incorporate advanced imaging techniques and detailed mapping solutions. This shift may result in challenges for the established cardiac mapping technologies, which may struggle to keep pace with the demand for more sophisticated treatment options. Consequently, the need for continual innovation and adaptation in the cardiac mapping sector is critical to address the complexities of modern cardiac care effectively.

Market Trends of the Global Cardiac Mapping Market

The Global Cardiac Mapping market is poised for significant growth during the forecast period, fueled by advancements in diagnostic technologies and a rising demand for precise cardiac testing. Medical device companies are at the forefront, innovating and introducing state-of-the-art mapping solutions that enhance the ability to diagnose and treat cardiac conditions. The need for accurate and comprehensive cardiac assessments is escalating due to the increasing prevalence of cardiovascular diseases and aging populations. Additionally, the integration of artificial intelligence and machine learning in cardiac mapping systems is further accelerating market expansion, positioning the sector for robust development in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Cardiac Mapping Market Size by Type & CAGR (2025-2032)

• Market Overview
• Contact Cardiac Mapping Systems
• Non-Contact Cardiac Mapping Systems

Global Cardiac Mapping Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Atrial Fibrillation
• Atrial Flutter
• Atrioventricular Nodal Reentrant Tachycardia (AVNRT)
• Other Indications

Global Cardiac Mapping Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals and Clinics
• Diagnostic Centers
• Other End Users

Global Cardiac Mapping Market Size & CAGR (2025-2032)

• North America (Type, Indication, End User)
  • US
  • Canada
• Europe (Type, Indication, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Indication, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Indication, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Indication, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Biosense Webster, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acutus Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biosig Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology (Beijing) Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• St. Jude Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CardioInsight Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EP Solutions SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CathVision ApS (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acutus Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedLumics (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations